C vs WFC

Citigroup presents a stark contradiction between market momentum and fundamental health. While the current price of $126.28 is well-supported by the Graham Number ($131.63), the Piotroski F-Score of 2/9 indicates severe fundamental weakness and deteriorating financial health. Despite a massive 1-year price surge of 104.9%, the company is facing negative earnings growth (-10.8% YoY) and bearish insider sentiment, including sales by the CFO. The stock is currently trading at a significant premium to its growth-based intrinsic value ($49.0), suggesting the market is pricing in a recovery that is not yet reflected in the data.

WFC presents a stark contrast between poor deterministic health and strong valuation/growth metrics. The Piotroski F-Score of 2/9 indicates weak financial health, which heavily penalizes the fundamental baseline. However, the stock is trading almost exactly at its Graham Number ($86.56), suggesting it is fairly valued defensively, while its intrinsic value ($166.83) suggests significant long-term upside. Steady earnings growth of 13.1% YoY and a sustainable payout ratio provide a buffer against the bearish insider sentiment and weak health scores.